Amgen (AMGN) Tops Q2 EPS by 76c, Offers Guidance
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $439.33 +1.29%
Financial Fact:
Interest and other income, net: 216M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Interest and other income, net: 216M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q2 EPS of $6.02, $0.76 better than the analyst estimate of $5.26. Revenue for the quarter came in at $9.18 billion versus the consensus estimate of $8.92 billion.
GUIDANCE:
Amgen sees FY2025 EPS of $20.20-$21.30, versus the consensus of $20.90. Amgen sees FY2025 revenue of $35-36 billion, versus the consensus of $35.36 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FTC files amicus brief challenging Amgen's Enbrel patent acquisition
- Myriad Uranium completes acquisition of Rush Rare Metals
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
